aurantiamide has been researched along with lamivudine in 1 studies
| Studies (aurantiamide) | Trials (aurantiamide) | Recent Studies (post-2010) (aurantiamide) | Studies (lamivudine) | Trials (lamivudine) | Recent Studies (post-2010) (lamivudine) |
|---|---|---|---|---|---|
| 8 | 0 | 7 | 7,025 | 1,425 | 2,177 |
| Protein | Taxonomy | aurantiamide (IC50) | lamivudine (IC50) |
|---|---|---|---|
| Capsid protein | Hepatitis B virus | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Cao, P; Hao, X; Huang, Z; Liang, G; Liu, C; Pan, W; Xu, B | 1 |
1 other study(ies) available for aurantiamide and lamivudine
| Article | Year |
|---|---|
Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives.
Topics: Antiviral Agents; Cell Line; Hepatitis B virus; Humans; Inhibitory Concentration 50; Lamivudine; Molecular Structure; Phenylalanine; Structure-Activity Relationship | 2009 |